Brigham Hyde

CEO - Atropos Health

Angel Investor Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$2.6M
total disclosed, rounds participated
Stages

About

CEO - Atropos Health

Portfolio · 1

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Brigham Hyde's primary investment focus?
Brigham Hyde has invested in the Health Tech & Life Sciences sector, with QuantHealth as a notable portfolio company.
Which company is a key part of Brigham Hyde's portfolio?
QuantHealth, an AI-based clinical trial simulation company founded in 2020, is a key part of Brigham Hyde's portfolio.
When did Brigham Hyde make their most recent investment?
Brigham Hyde made an investment in October 2022, which was their most recent recorded activity.
What stage of funding does Brigham Hyde typically participate in?
Brigham Hyde has participated in Seed stage funding rounds, as seen with their investment in QuantHealth.
Can you describe Brigham Hyde's investment in QuantHealth?
Brigham Hyde participated in a Seed round for QuantHealth in October 2022. QuantHealth is an AI-based clinical trial simulation company that raised $21.01M in its Series A round.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Radar intelligence

Patents

EPO1